Lloyd Mangnall

Lloyd Mangnall serves as the Chief Technology Officer at All Care Therapies since September 2022, with an extensive background in technology leadership across various organizations. Previously, Lloyd held the same position at InformedDNA and Centivo, focusing on technology platform re-envisioning, product engineering, and cybersecurity. At AbleTo Inc., Lloyd achieved significant growth, driving revenue from $12 million to $40 million and facilitating its acquisition by Optum/United Healthcare. Additional roles include overseeing technology strategy at Envision Physician Services and contributing to AMC Health and Blockchain in Healthcare Today as a board member. Lloyd's education includes executive training at Harvard Business School and a Bachelor's degree in Biological and Biomedical Sciences from UC Irvine.